Reviewing Nexentis Technologies (NXTS) & Its Peers

Nexentis Technologies (NASDAQ:NXTS) is one of 894 publicly-traded companies in the “Pharmaceuticals” industry, but how does it weigh in compared to its peers? We will compare Nexentis Technologies to related businesses based on the strength of its dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Risk and Volatility

Nexentis Technologies has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500. Comparatively, Nexentis Technologies’ peers have a beta of -0.05, meaning that their average stock price is 105% less volatile than the S&P 500.

Profitability

This table compares Nexentis Technologies and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nexentis Technologies	N/A	-304.79%	-178.91%
Nexentis Technologies Competitors	-2,393.19%	-220.45%	-16.12%

Valuation & Earnings

This table compares Nexentis Technologies and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nexentis Technologies	$210,000.00	-$4.00 million	-0.02
Nexentis Technologies Competitors	$3.54 billion	$3.17 billion	553.75

Nexentis Technologies’ peers have higher revenue and earnings than Nexentis Technologies. Nexentis Technologies is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current recommendations and price targets for Nexentis Technologies and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexentis Technologies	1	0	0	0	1.00
Nexentis Technologies Competitors	7820	13783	25793	1036	2.41

As a group, “Pharmaceuticals” companies have a potential upside of 24.80%. Given Nexentis Technologies’ peers stronger consensus rating and higher possible upside, analysts plainly believe Nexentis Technologies has less favorable growth aspects than its peers.

Institutional and Insider Ownership

61.2% of Nexentis Technologies shares are held by institutional investors. Comparatively, 32.5% of shares of all “Pharmaceuticals” companies are held by institutional investors. 6.5% of Nexentis Technologies shares are held by insiders. Comparatively, 14.1% of shares of all “Pharmaceuticals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Nexentis Technologies peers beat Nexentis Technologies on 10 of the 13 factors compared.

Nexentis Technologies Company Profile

N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company’s products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens.